Nanoviricides (NNVC) Payables (2011 - 2026)
Nanoviricides (NNVC) reported Payables of $2.31 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 80.0% from $1.28 million a year earlier and up 10.9% from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Payables (2011 - 2026) Analysis & Trends
Dating back to fiscal Q4 2011, Nanoviricides' Payables record includes 61 quarters.
- Payables has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 12.1% (FY2021 to FY2026).
- By fiscal year, Payables came in at $1.28 million in FY2025 (+16.8%), $1.1 million in FY2024 (+49.5%), $733,434 in FY2023 and $57,960 in FY2022 (-95.5%).
- Five-year quarterly Payables spans a low of $37,690 in fiscal Q1 2023 and a high of $2.31 million in fiscal Q1 2026.
- Year over year, Payables has now increased in each of the last ten quarters, with growth averaging 91.9% over the last eight quarters.
- The high point for year-over-year Payables in five years was fiscal Q3 2024 (growth of 444.5%); the low point was fiscal Q4 2022 (a decline of 95.5%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $2.08 million (Q3 2026), $2.29 million (Q2 2026) and $2.31 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Nanoviricides | 30.08 Mn | 17.74 Mn | - | 2.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.31 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 2.24 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 341,394.00 |
| Dec 31, 2023 | 831,227.00 |
| Sep 30, 2023 | 879,485.00 |
| Jun 30, 2023 | 733,434.00 |
| Mar 31, 2023 | 62,695.00 |
| Dec 31, 2022 | 39,291.00 |
| Sep 30, 2022 | 37,690.00 |
| Jun 30, 2022 | 57,960.00 |
| Mar 31, 2022 | 122,987.00 |
| Dec 31, 2021 | 153,180.00 |
| Sep 30, 2021 | 116,248.00 |
API Access
Nanoviricides Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();